bpc 157 peptide cancer BPC-157 and Erectile Dysfunction Everyone’s talking about peptides like

By subscribing you accept our Privacy Policy

Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties

Every reconstitution event carries a small risk of contamination or measurement error, so fewer events means more consistent results across your protocol

Rotate the injection site each week to help reduce reactions, and avoid injecting within 2 inches of your belly button